Life Tech Sues Bio-Rad for Infringing Protein-Production Patents | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies has filed suit against Bio-Rad for allegedly infringing four patents that cover methods for protein production, according to court documents filed last week.

Life Technologies filed a complaint on Aug. 13 in the US District Court for the District of Delaware charging Bio-Rad with infringing four patents: US Patent Nos. 6,703,484; 7,223,566; 7,259,242; and 7,265,206. All four patents describe methods for producing polypeptides in bacterial host cells and are assigned to Life Technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.